Dr S. Shahzad Mustafa looks ahead to ACAAI 2025, which will highlight advances in chronic urticaria treatment and ...

Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.

From relentless itching and painful flare-ups to sleepless nights and emotional exhaustion, eczema can take a serious toll on ...

Ingredients in some vitamin supplements may cause hives or a skin rash. Treatments include antihistamines and topical corticosteroids.

Around nearly every corner of the health and wellness space is a reminder to increase your fiber intake—this makes sense, as most Americans aren’t getting nearly enough. And the industry has quickly ...

This article reviews the interplay between histamine and serotonin in upper GI motility and highlights three clinical cases. It provides practical insights into assessment, treatment strategies, and ...